Jennifer Litton, MD
Advertisement
Articles by Jennifer Litton, MD
Not only are PARP inhibitors proving to be an efficacious treatment for patients with metastatic breast cancer, but they're also improving quality of life, too.
Advertisement
Latest Updated Articles
Benefits of PARP Inhibitor Use in Breast CancerJanuary 11th 2019
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients
2
FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications
3
Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer
4
Advocacy and Self-Care: Emily Beard on Oncology Navigation
5